The fast-growing life sciences consulting market is set to grow 9% annually through 2030, driven by advanced therapies, regulatory complexity, innovation, and digital health and transformation. Amidst fragmentation and high private equity involvement, the market is rapidly becoming a hot-spot for M&A. Download our latest report to explore growth drivers, M&A trends, valuation insights, and the key opportunities for buyers and sellers to take advantage of consolidation.
Wed Sep 11, 2024